See the DrugPatentWatch profile for loratadine

Yes, there are patents on loratadine and phenylephrine combinations. According to the information provided, the FDA has approved a combination drug product containing loratadine and phenylephrine [2]. Loratadine is an antihistamine used to relieve allergic symptoms, while phenylephrine is a decongestant [3][1].

A search for patents related to the tradename "LORATADINE" on DrugPatentWatch returns several results, including patents for combination products containing loratadine and phenylephrine [1]. These patents may cover various aspects of the products, such as the specific formulation, manufacturing process, or use in treating certain conditions.

It's important to note that while there are patents on these combination products, they may have expired or will expire in the future. Once a patent expires, generic versions of the product can be produced, increasing accessibility and potentially reducing costs for consumers.

In summary, based on the provided information, there are patents on loratadine and phenylephrine combinations, and these patents may cover various aspects of the products.

Sources:

[1] DrugPatentWatch. (n.d.). Loratadine. Retrieved from <https://www.drugpatentwatch.com/p/tradename/LORATADINE>

[2] U.S. Food and Drug Administration. (2022). Approval Letter. Retrieved from <https://www.fda.gov/media/171915/download>

[3] Wikipedia. (2023, February 1). Loratadine. Retrieved from <https://en.wikipedia.org/wiki/Loratadine>